{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T05:09:53Z","timestamp":1776834593708,"version":"3.51.2"},"reference-count":31,"publisher":"Tsinghua University Press","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.26599\/1671-5411.2023.06.003","type":"journal-article","created":{"date-parts":[[2023,8,4]],"date-time":"2023-08-04T08:09:18Z","timestamp":1691136558000},"page":"448-458","source":"Crossref","is-referenced-by-count":7,"title":["Nocturnal hypertension and riser pattern are associated with heart failure rehospitalization in patients with heart failure with preserved ejection fraction"],"prefix":"10.26599","volume":"20","author":[{"given":"Gang","family":"HUANG","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Han","family":"LIU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"ZHANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Xin","family":"ZHU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"HE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tian-Bo","family":"WANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"ZHANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-Bo","family":"XU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"11138","reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1002\/ejhf.1858","article-title":"Epidemiology of heart failure","volume":"22","author":"A Groenewegen","year":"2020","unstructured":"A Groenewegen. Epidemiology of heart failure. 2020, 22: 1342-1356.","journal-title":"Eur J Heart Fail"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1002\/ejhf.1629","article-title":"Prevalence of heart failure and left ventricular dysfunction in China: the China Hypertension Survey, 2012\u20132015","volume":"21","author":"G Hao","year":"2019","unstructured":"G Hao. Prevalence of heart failure and left ventricular dysfunction in China: the China Hypertension Survey, 2012\u20132015. 2019, 21: 1329-1337.","journal-title":"Eur J Heart Fail"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1002\/ejhf.1594","article-title":"Survival of patients with chronic heart failure in the community: a systematic review and meta-analysis","volume":"21","author":"NR Jones","year":"2019","unstructured":"NR Jones. Survival of patients with chronic heart failure in the community: a systematic review and meta-analysis. 2019, 21: 1306-1325.","journal-title":"Eur J Heart Fail"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/clc.23754","article-title":"Characteristics and long-term prognosis of patients with reduced, mid-range, and preserved ejection fraction: a systemic review and meta-analysis","volume":"45","author":"M Liang","year":"2022","unstructured":"M Liang. Characteristics and long-term prognosis of patients with reduced, mid-range, and preserved ejection fraction: a systemic review and meta-analysis. 2022, 45: 5-17.","journal-title":"Clin Cardiol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1093\/eurheartj\/ehq426","article-title":"Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment","volume":"32","author":"BA Borlaug","year":"2011","unstructured":"BA Borlaug. Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment. 2011, 32: 670-679.","journal-title":"Eur Heart J"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ijcard.2018.04.031","article-title":"Low diastolic blood pressure and adverse outcomes in heart failure with preserved ejection fraction","volume":"263","author":"T Tsujimoto","year":"2018","unstructured":"T Tsujimoto. Low diastolic blood pressure and adverse outcomes in heart failure with preserved ejection fraction. 2018, 263: 69-74.","journal-title":"Int J Cardiol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1001\/jama.295.24.2859","article-title":"Diurnal blood pressure pattern and risk of congestive heart failure","volume":"295","author":"E Ingelsson","year":"2006","unstructured":"E Ingelsson. Diurnal blood pressure pattern and risk of congestive heart failure. 2006, 295: 2859-2866.","journal-title":"JAMA"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1161\/CIRCULATIONAHA.120.049730","article-title":"Nighttime blood pressure phenotype and cardiovascular prognosis: practitioner-based nationwide JAMP study","volume":"142","author":"K Kario","year":"2020","unstructured":"K Kario. Nighttime blood pressure phenotype and cardiovascular prognosis: practitioner-based nationwide JAMP study. 2020, 142: 1810-1820.","journal-title":"Circulation"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"182","DOI":"10.11909\/j.issn.1671-5411.2019.03.014","article-title":"2018 Chinese guidelines for prevention and treatment of hypertension: a report of the Revision Committee of Chinese Guidelines for Prevention and Treatment of Hypertension","volume":"16","author":"Committee for Guideline Revision Joint","year":"2019","unstructured":"Committee for Guideline Revision Joint. 2018 Chinese guidelines for prevention and treatment of hypertension: a report of the Revision Committee of Chinese Guidelines for Prevention and Treatment of Hypertension. 2019, 16: 182-241.","journal-title":"J Geriatr Cardiol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"313","DOI":"10.3969\/j.issn.1000-3614.2021.04.001","article-title":"[2020 Chinese hypertension league guidelines on ambulatory blood pressure monitoring]","volume":"36","author":"Group of the 2020 Chinese Hypertension League Guidelines on Ambulatory Blood Pressure Monitoring Writing","year":"2021","unstructured":"Group of the 2020 Chinese Hypertension League Guidelines on Ambulatory Blood Pressure Monitoring Writing. [2020 Chinese hypertension league guidelines on ambulatory blood pressure monitoring]. 2021, 36: 313-328.","journal-title":"Chin Circulation J"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"TA McDonagh","year":"2021","unstructured":"TA McDonagh. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. 2021, 42: 3599-3726.","journal-title":"Eur Heart J"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"760","DOI":"10.3760\/cma.j.issn.0253-3758.2018.10.004","article-title":"[Chinese guidelines for the diagnosis and treatment of heart failure 2018]","volume":"46","author":"Failure Group of Chinese Society of Cardiology of Chinese Medical Association; Chinese Heart Failure Association of Chinese Medical Doctor Association; Editorial Board of Chinese Journal of Cardiology Heart","year":"2018","unstructured":"Failure Group of Chinese Society of Cardiology of Chinese Medical Association; Chinese Heart Failure Association of Chinese Medical Doctor Association; Editorial Board of Chinese Journal of Cardiology Heart. [Chinese guidelines for the diagnosis and treatment of heart failure 2018]. 2018, 46: 760-789.","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1056\/NEJMoa051530","article-title":"Outcome of heart failure with preserved ejection fraction in a population-based study","volume":"355","author":"RS Bhatia","year":"2006","unstructured":"RS Bhatia. Outcome of heart failure with preserved ejection fraction in a population-based study. 2006, 355: 260-269.","journal-title":"N Engl J Med"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jacc.2005.09.022","article-title":"Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database","volume":"47","author":"CW Yancy","year":"2006","unstructured":"CW Yancy. Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database. 2006, 47: 76-84.","journal-title":"J Am Coll Cardiol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.jchf.2022.04.006","article-title":"Apparent treatment-resistant hypertension across the spectrum of heart failure phenotypes in the Swedish HF Registry","volume":"10","author":"AM Jackson","year":"2022","unstructured":"AM Jackson. Apparent treatment-resistant hypertension across the spectrum of heart failure phenotypes in the Swedish HF Registry. 2022, 10: 380-392.","journal-title":"JACC Heart Fail"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1002\/ehf2.12295","article-title":"Effectiveness of a transition plan at discharge of patients hospitalized with heart failure: a before-and-after study","volume":"5","author":"A Garnier","year":"2018","unstructured":"A Garnier. Effectiveness of a transition plan at discharge of patients hospitalized with heart failure: a before-and-after study. 2018, 5: 657-667.","journal-title":"ESC Heart Fail"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1161\/HYPERTENSIONAHA.121.17440","article-title":"Nocturnal hypertension and heart failure: mechanisms, evidence, and new treatments","volume":"78","author":"K Kario","year":"2021","unstructured":"K Kario. Nocturnal hypertension and heart failure: mechanisms, evidence, and new treatments. 2021, 78: 564-577.","journal-title":"Hypertension"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1253\/circj.CJ-16-0740","article-title":"Riser pattern is a novel predictor of adverse events in heart failure patients with preserved ejection fraction","volume":"81","author":"T Komori","year":"2017","unstructured":"T Komori. Riser pattern is a novel predictor of adverse events in heart failure patients with preserved ejection fraction. 2017, 81: 220-226.","journal-title":"Circ J"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1002\/ehf2.12500","article-title":"Differences in blood pressure riser pattern in patients with acute heart failure with reduced mid-range and preserved ejection fraction","volume":"6","author":"T Ueda","year":"2019","unstructured":"T Ueda. Differences in blood pressure riser pattern in patients with acute heart failure with reduced mid-range and preserved ejection fraction. 2019, 6: 1057-1067.","journal-title":"ESC Heart Fail"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1161\/HYPERTENSIONAHA.120.15420","article-title":"Heart failure and atrial fibrillation modify the associations of nocturnal blood pressure dipping pattern with mortality in hemodialysis patients","volume":"76","author":"CC Mayer","year":"2020","unstructured":"CC Mayer. Heart failure and atrial fibrillation modify the associations of nocturnal blood pressure dipping pattern with mortality in hemodialysis patients. 2020, 76: 1231-1239.","journal-title":"Hypertension"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1161\/01.CIR.100.15.1635","article-title":"Diuretics shift circadian rhythm of blood pressure from nondipper to dipper in essential hypertension","volume":"100","author":"T Uzu","year":"1999","unstructured":"T Uzu. Diuretics shift circadian rhythm of blood pressure from nondipper to dipper in essential hypertension. 1999, 100: 1635-1638.","journal-title":"Circulation"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1161\/HYPERTENSIONAHA.118.10971","article-title":"Nocturnal hypertension: new technology and evidence","volume":"71","author":"K Kario","year":"2018","unstructured":"K Kario. Nocturnal hypertension: new technology and evidence. 2018, 71: 997-1009.","journal-title":"Hypertension"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1161\/HYPERTENSIONAHA.108.116368","article-title":"Adrenergic, metabolic, and reflex abnormalities in reverse and extreme dipper hypertensives","volume":"52","author":"G Grassi","year":"2008","unstructured":"G Grassi. Adrenergic, metabolic, and reflex abnormalities in reverse and extreme dipper hypertensives. 2008, 52: 925-931.","journal-title":"Hypertension"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S0895-7061(01)02251-8","article-title":"Nighttime blood pressure dipping: the role of the sympathetic nervous system","volume":"15","author":"A Sherwood","year":"2002","unstructured":"A Sherwood. Nighttime blood pressure dipping: the role of the sympathetic nervous system. 2002, 15: 111-118.","journal-title":"Am J Hypertens"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"12403","DOI":"10.1038\/s41598-018-30321-z","article-title":"Hyperuricemia is associated with atrial fibrillation prevalence in very elderly: a community based study in Chengdu, China","volume":"8","author":"G Huang","year":"2018","unstructured":"G Huang. Hyperuricemia is associated with atrial fibrillation prevalence in very elderly: a community based study in Chengdu, China. 2018, 8: 12403.","journal-title":"Sci Rep"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"8678","DOI":"10.1038\/s41598-020-65605-w","article-title":"Hyperuricemia is associated with metabolic syndrome in the community very elderly in Chengdu","volume":"10","author":"G Huang","year":"2020","unstructured":"G Huang. Hyperuricemia is associated with metabolic syndrome in the community very elderly in Chengdu. 2020, 10: 8678.","journal-title":"Sci Rep"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1038\/s41598-017-01042-6","article-title":"Hyperuricemia is associated with cardiovascular diseases clustering among very elderly women: a community based study in Chengdu, China","volume":"7","author":"G Huang","year":"2017","unstructured":"G Huang. Hyperuricemia is associated with cardiovascular diseases clustering among very elderly women: a community based study in Chengdu, China. 2017, 7: 996.","journal-title":"Sci Rep"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"3435","DOI":"10.1093\/eurheartj\/ehac320","article-title":"Uric acid and sodium-glucose cotransporter-2 inhibition with empagliflozin in heart failure with reduced ejection fraction: the EMPEROR-reduced trial","volume":"43","author":"W Doehner","year":"2022","unstructured":"W Doehner. Uric acid and sodium-glucose cotransporter-2 inhibition with empagliflozin in heart failure with reduced ejection fraction: the EMPEROR-reduced trial. 2022, 43: 3435-3446.","journal-title":"Eur Heart J"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1016\/j.amjcard.2017.06.057","article-title":"Prevalence of hyperuricemia in patients with acute heart failure with either reduced or preserved ejection fraction","volume":"120","author":"A Palazzuoli","year":"2017","unstructured":"A Palazzuoli. Prevalence of hyperuricemia in patients with acute heart failure with either reduced or preserved ejection fraction. 2017, 120: 1146-1150.","journal-title":"Am J Cardiol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.amjcard.2020.04.026","article-title":"Comparison of characteristics and outcomes of patients with heart failure with preserved ejection fraction with versus without hyperuricemia or gout","volume":"127","author":"AP Carnicelli","year":"2020","unstructured":"AP Carnicelli. Comparison of characteristics and outcomes of patients with heart failure with preserved ejection fraction with versus without hyperuricemia or gout. 2020, 127: 64-72.","journal-title":"Am J Cardiol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1002\/ehf2.12734","article-title":"Impact of plasma xanthine oxidoreductase activity in patients with heart failure with preserved ejection fraction","volume":"7","author":"K Watanabe","year":"2020","unstructured":"K Watanabe. Impact of plasma xanthine oxidoreductase activity in patients with heart failure with preserved ejection fraction. 2020, 7: 1735-1743.","journal-title":"ESC Heart Fail"}],"container-title":["Journal of Geriatric Cardiology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,8,4]],"date-time":"2023-08-04T08:09:26Z","timestamp":1691136566000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.sciopen.com\/article\/10.26599\/1671-5411.2023.06.003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"URL":"https:\/\/doi.org\/10.26599\/1671-5411.2023.06.003","relation":{},"ISSN":["1671-5411"],"issn-type":[{"value":"1671-5411","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]}}}